The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Purifloh (PO3) Chairman Bill Parfet has announced his resignation from the head position and as the company’s Director of the Board
  • The former Chairman announced the news this morning, stating the resignation was effective immediately
  • Bill has thanked the company for the opportunity but is focused on spending more time with his family in retirement
  • Purifloh Director Carl Le Souef will step into the Chairman role on an interim basis
  • Shares in Purifloh have opened trading down 21.1 per cent for $1.50

Purifloh (PO3) Chairman, Bill Parfet, has announced his resignation from the Chairman position and stepped down as the Director of the Board.

In a statement, Bill thanked the company for the opportunity and said he had decided to spend more time with his family in retirement.

“It has been an honour to lead Purifloh over the past 12 months though I now wish to spend more time in retirement with my family,” he said.

“I depart with nothing but good wishes and best regards for the company, my fellow Board Members and the management team,” he added.

The former Chairman will retain his shareholding in Purifloh and has offered his continued support to the company.

Bill will be replaced by current Purifloh Director Carl Le Souef, who will step into the Chairman role on an interim basis.

Carl also controls the company’s major shareholder, the business Dilato Holdings.

“All shareholders owe a debt of gratitude towards Bill for his investment in Purifloh, together with his efforts on behalf of the company,” the new interim Chairman said.

“We thank Bill for his support and leadership and wish him the very best in his retirement,” he added.

The director also promised to release another update on Purifloh’s activities soon, with the company announcing its annual report yesterday.

The company, which creates technology for purifying air, water and surfaces, announced the leadership news before market open on Friday.

Shares in the company have since dropped as investors react, trading down 21.1 per cent, with shares worth $1.50 at 10:38 am AEST.

PO3 by the numbers
More From The Market Online
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…
Man holding health IT icon

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision…
Handshake concept

Knosys Ltd inks 2 year software contract extension with Healthdirect

Knosys (ASX:KNO) has confirmed its existing SaaS relationship with Healthdirect has been extended by 2 years.
AI image of molecular structure

Race identifies 39 new molecules with potential to inhibit cancer-associated protein

Race Oncology Ltd has completed a successful drug discovery program started in 2022 at Monash University…